UBS Group
GEVA

UBS Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

UBS Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,135
Closed -$208K – 7080
2015
Q1 		$208K Sell
2,135
-1,140
-35% -$111K ﹤0.01% 3768
2014
Q4 		$304K Buy
+3,275
New +$304K ﹤0.01% 3506